let’s get in touch
Whether you’re a healthcare professional, patient, advocate, enthusiast, or potential partner—we’re here to listen, support, and collaborate. Reach out to discuss how we can work together to make treatment more precise and more human.
contact our team, we’ll get back to you shortly
We look forward to helping address your goals, challenges or questions. Fill out the form and a member of our team will be in touch as soon as possible.
stay ahead of the curve
Get the latest on clinical innovation, product updates, and stories from the field — delivered to your inbox.
frequently asked questions
Does the presence of the stent impact the radiation beam or planning accuracy?
No. Stentra™ is fabricated from low-density, non-metallic materials that are radiographically visible on CT but do not attenuate or scatter the therapeutic radiation beam. It integrates seamlessly into standard treatment planning workflows and does not require dose modification or beam compensation, preserving planning accuracy and clinical efficiency.
Is Stentra™ reimbursable under existing CPT codes?
Yes. Stentra™ is eligible for reimbursement using current CPT codes for radiation therapy immobilization devices—typically CPT 77334 for custom, complex devices. Reimbursement amounts will vary based on payer policies, correct code selection, and supporting documentation. We supply clients with onboarding tools including coding guidance and claim-ready documentation templates to optimize codability and reimbursement.
How long does it take to receive a custom device?
After your oral scan is submitted, your custom Stentra™ stent is designed, 3D printed and delivered within 72 hours. It’s typically ready before your first radiation treatment session, ensuring there’s no delay in your care.
When should I talk to my doctor about this ?
As early as possible — ideally before your simulation scan or the start of radiation treatment. This is when your care team plans how therapy will be delivered. Bringing up options like Stentra™ early ensures your comfort, safety, and long-term quality of life are part of the conversation. Use this guide to help start that discussion.
What are the benefits of participating in the Stentra™ Proof of Value Program?
The program offers your team direct experience with Stentra™—Kallisio’s FDA-cleared, patient-specific oral stent for head and neck radiation therapy. It enables evaluation of clinical benefits such as improved patient positioning, potential reduction in oral mucositis, and enhanced treatment tolerance. Additionally, your team can assess workflow integration, billing feasibility using existing CPT codes, and potential long-term return on investment.
What’s required from my clinic to get started in the Stentra™ Proof of Value Program ?
Select up to 10 head and neck cancer patients and assign a team member to upload cases via Kallisio’s secure clinical portal. An intraoral scanner is preferred—Kallisio can assist if one is not available. Device fit is verified during CT simulation. Follow-up is required to share toxicity and setup reproducibility data, which are essential to assessing clinical and operational impact.
What is Kallisio and what problem are you solving?
Kallisio is a medical innovation company focused on improving the quality of care in treatments through technological precision advancements. Our mission is to enhance precision, comfort, and outcomes for patients.
Is Kallisio specialized in oncology ?
Oncology is our first area of focus, starting with head and neck cancer. But our technology is designed to scale across multiple specialties where patient-specific solutions can improve treatment outcomes.
Who is Stentra™ designed for?
Stentra™ is designed for patients undergoing radiation therapy for head and neck cancers. It is particularly beneficial for those who need precise tongue and jaw positioning during treatment, including individuals with complex anatomies or without natural teeth (edentulous). Each device is customized to the patient’s unique anatomy to help improve the accuracy of radiation delivery and reduce exposure to healthy tissues. Ask your doctor if Stentra™ may be appropriate for your treatment plan.
What is Kallisio and what problem are you solving?
Kallisio is a medical innovation company focused on improving the quality of care in treatments through technological precision advancements. Our mission is to enhance precision, comfort, and outcomes for patients.
Is Kallisio specialized in oncology ?
Oncology is our first area of focus, starting with head and neck cancer. But our technology is designed to scale across multiple specialties where patient-specific solutions can improve treatment outcomes.
Who is Stentra™ designed for?
Stentra™ is designed for patients undergoing radiation therapy for head and neck cancers. It is particularly beneficial for those who need precise tongue and jaw positioning during treatment, including individuals with complex anatomies or without natural teeth (edentulous). Each device is customized to the patient’s unique anatomy to help improve the accuracy of radiation delivery and reduce exposure to healthy tissues. Ask your doctor if Stentra™ may be appropriate for your treatment plan.
Does the presence of the stent impact the radiation beam or planning accuracy?
No. Stentra™ is fabricated from low-density, non-metallic materials that are radiographically visible on CT but do not attenuate or scatter the therapeutic radiation beam. It integrates seamlessly into standard treatment planning workflows and does not require dose modification or beam compensation, preserving planning accuracy and clinical efficiency.
Is Stentra™ reimbursable under existing CPT codes?
Yes. Stentra™ is eligible for reimbursement using current CPT codes for radiation therapy immobilization devices—typically CPT 77334 for custom, complex devices. Reimbursement amounts will vary based on payer policies, correct code selection, and supporting documentation. We supply clients with onboarding tools including coding guidance and claim-ready documentation templates to optimize codability and reimbursement.
How long does it take to receive a custom device?
After your oral scan is submitted, your custom Stentra™ stent is designed, 3D printed and delivered within 72 hours. It’s typically ready before your first radiation treatment session, ensuring there’s no delay in your care.
When should I talk to my doctor about this?
As early as possible — ideally before your simulation scan or the start of radiation treatment. This is when your care team plans how therapy will be delivered. Bringing up options like Stentra™ early ensures your comfort, safety, and long-term quality of life are part of the conversation. Use this guide to help start that discussion.
What are the benefits of participating in the Stentra™ Proof of Value Program?
The program offers your team direct experience with Stentra™—Kallisio’s FDA-cleared, patient-specific oral stent for head and neck radiation therapy. It enables evaluation of clinical benefits such as improved patient positioning, potential reduction in oral mucositis, and enhanced treatment tolerance. Additionally, your team can assess workflow integration, billing feasibility using existing CPT codes, and potential long-term return on investment.
What’s required from my clinic to get started in the Stentra™ Proof of Value Program?
Select up to 10 head and neck cancer patients and assign a team member to upload cases via Kallisio’s secure clinical portal. An intraoral scanner is preferred—Kallisio can assist if one is not available. Device fit is verified during CT simulation. Follow-up is required to share toxicity and setup reproducibility data, which are essential to assessing clinical and operational impact.